{
    "organizations": [],
    "uuid": "5e909e324dff5fb542d823a8de4dbda3f7ffdc5b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-australian-pharmaceutical-industri/brief-australian-pharmaceutical-industries-posts-hy-net-profit-attributable-24-9-mln-idUSFWN1RV107",
    "ord_in_thread": 0,
    "title": "BRIEF-Australian Pharmaceutical Industries Posts HY Net Profit Attributable $24.9 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Australian Pharmaceutical Industries Ltd:\n* HY REVENUE FROM ORDINARY ACTIVITIES $2.01 BILLION VERSUS $2.02 BILLION\n* HY NET PROFIT ATTRIBUTABLE $24.9 MILLION VERSUS $29.1 MILLION\n* DECLARES INTERIM DIVIDEND OF 3.5 CENTS PER SHARE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T07:26:00.000+03:00",
    "crawled": "2018-04-19T15:17:35.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "australian",
        "pharmaceutical",
        "industry",
        "ltd",
        "hy",
        "revenue",
        "ordinary",
        "activity",
        "billion",
        "versus",
        "billion",
        "hy",
        "net",
        "profit",
        "attributable",
        "million",
        "versus",
        "million",
        "declares",
        "interim",
        "dividend",
        "cent",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}